Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers
An Open-label, Pilot Trial to Assess the Effects of a Dietary Supplement on Fasting Lipoprotein Lipids and a Marker of Inflammation in Men and Women With Above-desirable Levels of Low-density Lipoprotein Cholesterol
Sponsor: Midwest Center for Metabolic and Cardiovascular Research
Listed as NCT03118583, this NA trial focuses on Healthy Volunteers and remains completed. Sponsored by Midwest Center for Metabolic and Cardiovascular Research, it has been updated 5 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Midwest Center for Metabolic and Cardiovascular Research
For direct contact, visit the study record on ClinicalTrials.gov .